Acasă › Obezitate › Arizona › Tucson
Studii clinice pentru Obezitate în Tucson, AZ
17 studii pentru Obezitate caută participanți în și în jurul orașului Tucson (în aproximativ 50 km). Deschideți un studiu pentru a vedea criteriile de eligibilitate și cum să contactați echipa de cercetare.
Text oficial al studiului (în engleză)
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
În curs de recrutareFaza 2
- Pima Heart, Tucson
- Eclipse Clinical Research, Tucson
A Platform Trial for Pediatric Participants With Obesity or Overweight (LY900040)
În curs de recrutareFaza 3
- University of Arizona, Tucson
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
În curs de recrutareFaza 3
- Tucson Clinical Research Institute, Tucson
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
În curs de recrutareFaza 3
- Novak Clinical Research - Tucson - North La Cholla Boulevard, Tucson
A Study to Evaluate Effect of AZD6234 in Adult Participants With Type 2 Diabetes Mellitus and Obesity or Overweight
În curs de recrutareFaza 3
- Research Site, Tucson
Efficacy and Safety of Eloralintide (LY3841136) in Participants With Osteoarthritis Knee Pain and Obesity or Overweight
În curs de recrutareFaza 3
- Tucson Orthopaedic Institute - North Wyatt Drive, Tucson
A Study to Investigate Weight Management With Macupatide and Eloralintide, Alone or in Combination, in Adult Participants With Obesity or Overweight
În curs de recrutareFaza 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Weight-Related Comorbidities
În curs de recrutareFaza 3
- AURORA-1 Clinical Site, Tucson
A Study of Once-daily Oral ASC30 to Evaluate the Efficacy and Safety in Adult Participants With Obesity or Overweight With Type 2 Diabetes
În curs de recrutareFaza 3
- AURORA-2 Clinical Site, Tucson
Maridebart Cafraglutide in Heart Failure With Preserved or Mildly Reduced Ejection Fraction and Obesity
În curs de recrutareFaza 3
- Pima Heart and Vascular Clinical Research, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
În curs de recrutareFaza 3
- Arizona Clinical Trials, Tucson
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight Without Type 2 Diabetes
În curs de recrutareFaza 3
- Arizona Clinical Trials, Tucson
A Study of Aleniglipron in Adults With Obesity or Overweight and Type 2 Diabetes Mellitus (ACCOMPLISH-2)
În curs de recrutareFaza 3Voluntari sănătoși bineveniți
- ACCOMPLISH-2 Research Site, Tucson
A Master Protocol Study (LY900038) of Multiple Intervention-Specific-Appendices (ISAs) in Adult Participants With Obesity or Overweight
În curs de recrutareFaza 2
- The Institute for Liver Health II dba Arizona Liver Health-Tucson, Tucson
A Study of Macupatide (LY3532226) and Eloralintide (LY3841136), Alone or in Combination, in Adults With Obesity or Overweight and With Type 2 Diabetes
În curs de recrutareFaza 2
- Pima Heart, Tucson
Efficacy and Safety of Aleniglipron in Participants With Obesity or Overweight With a Weight-Related Comorbidity (ACCOMPLISH-1)
În curs de recrutareFaza 3
- ACCOMPLISH-1 Research Site, Tucson
A Study to Evaluate ALN-CIDEB in Adult Participants With Metabolic Dysfunction-Associated Steatotic Liver Disease or With Metabolic Dysfunction-Associated Steatohepatitis (MASLD/MASH)
În curs de recrutareFaza 1/2
- Adobe Clinical Research, Tucson
Studii pentru Obezitate în alte orașe
- Houston, TX43 studii
- Chicago, IL41 studii
- New York City, NY40 studii
- San Antonio, TX40 studii
- Washington, DC33 studii
- Orlando, FL31 studii
- Dallas, TX30 studii
- Boston, MA28 studii
- Las Vegas, NV27 studii
- Miami, FL27 studii
- Baltimore, MD25 studii
- Jacksonville, FL25 studii
Alte studii în Tucson
- Cancer de sân20 studii
- Cancer pulmonar cu celule non-pătrate17 studii
- Supraponderalitate15 studii
- Cancer metastatic14 studii
- Cancer (toate tipurile)12 studii
- Boli cardiovasculare12 studii
- Cancer colorectal11 studii
- Cancer de prostată11 studii
- Boală hepatică steatoasă10 studii
- Insuficiență cardiacă10 studii
- Hipertensiune arterială10 studii
- Diabet de tip 210 studii
Sursă: ClinicalTrials.gov, date preluate la 5 oct. 2026. Fiecare studiu are propriile criterii de eligibilitate; echipa de cercetare decide cine poate participa.